Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814927 · ClinicalTrials.gov registry record · Phase 4
Impact of Contraceptives on Cervico-Vaginal Mucosa
A Phase 4 study, sponsored by Eastern Virginia Medical School.
- Completed
- Registry status
- Phase 4
- Development phase
- 112
- Enrollment target
NCT04814927 is a Phase 4 study that has completed, run by Eastern Virginia Medical School. The registered enrollment target is 112 participants.
The verdict
NCT04814927, a Phase 4 study, has completed, sponsored by Eastern Virginia Medical School.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 112 participants
- Enrollment target
Study Summary
UMPALA is a research study to look at the effect of four different, approved contraceptives on the cervical and vaginal tissues as well as on factors in the blood. Participants will have a baseline examination then receive one of four approved, marketed contraceptive products. Cervico-vaginal assessments will take place 4 weeks after contraceptive initiation and 3 months after to assess changes in mucosal safety after use of various contraceptive products in young, healthy, HIV uninfected women.
Interventions
- DRUG Etonogestrel implant
- DRUG Levonorgestrel IUS
- DRUG Copper IUD
- DRUG DMPA Sub-cutaneous
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2022-12-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04814927
The ClinicalTrials.gov registry entry for NCT04814927 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eastern Virginia Medical School, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Etonogestrel implant is the first listed.
NCT04814927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04814927 about?
NCT04814927 is a clinical study titled "Impact of Contraceptives on Cervico-Vaginal Mucosa". UMPALA is a research study to look at the effect of four different, approved contraceptives on the cervical and vaginal tissues as well as on factors in the blood. Participants will have a baseline examination then receive one of four approved, marketed contraceptive products. Cervico-vaginal assess...
What is the current status of trial NCT04814927?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 112 participants. The study started on 2021-03-01. Estimated completion is 2022-12-15.
What interventions are being tested in trial NCT04814927?
The interventions under investigation include: Etonogestrel implant (DRUG), Levonorgestrel IUS (DRUG), Copper IUD (DRUG), DMPA Sub-cutaneous (DRUG).
Who is sponsoring clinical trial NCT04814927?
This trial is sponsored by Eastern Virginia Medical School, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.